In addition, losartan was reported to reduce IFN gamma, IL-6, IL-17F, and IL-22 production from stimulated PBMCs from RA patients [20], whereas this was not seen when enalapril or valsartan were used, suggesting that anti-inflammatory properties might be drug-specific. This evidence concerns the gene IL6 and rheumatoid arthritis.